(5R)-2-methyloxane-3,4,5-triol

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 氧烷类
• 英文名称: (5R)-2-methyloxane-3,4,5-triol
• 化学式: C₆H₁₂O₄
• 分子量: 148.16
• InChiKey: KBVSUNBCTPQWJL-FPPIULTPSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.6
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  69.9
• 氢给体数：
  3
• 氢受体数：
  4

文献信息

• TREATMENT COMPOSITIONS COMPRISING CATIONIC POLY ALPHA-1,6-GLUCAN ETHERS
  申请人：The Procter & Gamble Company

  公开号：EP3926029A1

  公开（公告）日：2021-12-22

  Treatment compositions, such as fabric care or dish care compositions, that include poly alpha-1,6-glucan ether compounds, which include poly alpha-1,6-glucans substituted with at least one positively charged organic group, the compounds being characterized by, for example, a degree of substitution of about 0.001 to about 3.0, and optionally, where about 3% or more of the backbone glucose monomer units have branches via alpha-1,2- and/or alpha-1,3-glycosidic linkages. Methods related to making and using such compositions.

  包括聚α-1,6-葡聚糖醚化合物的护理组合物，如织物护理或餐具护理组合物，其中包括用至少一个带正电荷的有机基团取代的聚α-1,6-葡聚糖，该化合物的特征是，例如，取代度约为0.001至约3.0，可选地，其中约3%或更多的骨架葡萄糖单体单元通过α-1,2-和/或α-1,3-糖苷键具有分支。与制造和使用此类组合物有关的方法。
• Protoescigenin derivative, process of its preparation, use of said compound and pharmaceutical composition comprising that compound
  申请人：Warszawski Uniwersytet Medyczny

  公开号：US10370404B2

  公开（公告）日：2019-08-06

  Described herein is compound including a protoescigenin derivative having pharmacological properties. Also described are a process of its preparation, and the use of such a compound as a medicament, especially for treating vascular disorders. A pharmaceutical composition comprising such compound is further described.

  本文描述的化合物包括一种具有药理特性的原橙皮苷衍生物。还描述了其制备过程，以及这种化合物作为药物的用途，特别是用于治疗血管疾病。还描述了一种包含这种化合物的药物组合物。
• POLYMER DOT COMPOSITIONS AND RELATED METHODS
  申请人：University of Washington through its Center for Commercialization

  公开号：EP2972349B1

  公开（公告）日：2019-10-23
• [EN] PROCESS FOR PREPARATION OF 3,24;16,22-DI-O,O-ISOPROPYLIDENEPROTOESCIGENIN AND CRYSTALLINE FORMS THEREOF<br/>[FR] PROCÉDÉ DE PRÉPARATION DE 3,24;16,22-DI-O,O-ISOPROPYLIDÈNEPROTOESCIGÉNINE ET FORMES CRISTALLINES DE CELUI-CI
  申请人：INST FARMACEUTYCZNY

  公开号：WO2014104905A1

  公开（公告）日：2014-07-03

  Process for preparation of 3,24;16,22-di-O,O-isopropylideneprotoescigenin comprises acetonidation of protoescigenin monohydrate in the mixture consisting of 0 - 100% vol. of acetone and 100 - 0% vol. of 2,2-dimethoxypropane, in presence of catalytic amount of an acid, furnishing precipitation of the crystalline product from the reaction mixture. 3,24; 16,22 -Di-O,O- isopropylideneprotoescigenin is isolated either in crystalline form A or B.